|4.45||-0.04 / -0.89%|
As of 3:59pm ET
|4.55||+0.10 / +2.25%|
The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +214.61% increase from the last price of 4.45.
The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.